Chronic Infammatory Demyelinating Polyneuropathy Chronic inflammatory demyelinating polyneuropathy (CIDP) is a neurological disorder characterized by progressive weakness and impaired sensory function in the legs and arms. CIDP is caused by damage to the myelin sheath (the fatty covering that wraps around and protects nerve fibers) of the peripheral nerves. It can occur at any age and in both genders. It often presents with symptoms that include tingling or numbness (beginning in the toes and fingers), weakness of the arms and legs, loss of deep tendon reflexes, fatigue, and abnormal sensations. CIDP is closely related to Guillain-Barre syndrome and it is considered the chronic counterpart of that acute disease. Treatment for CIDP includes corticosteroids such as prednisone, which may be prescribed alone or in combination with immunosuppressant drugs. Plasmapheresis (plasma exchange) and immunoglobulin (IVIG/SCIG) therapy are effective. IVIG/SCIG may be used as a first-line therapy. Physiotherapy may improve muscle strength, function and mobility, and minimize the shrinkage of muscles and tendons and distortions of the joints.
Your advocate will help you navigate and coordinate your course of treatment and assist in your healthcare needs.
Assists with navigating the complexities of health insurance and ensure that your plan is affordable and appropriate for your health care needs.
If necessary, your advocate will provide information on Health Insurance Co-Pay assistance and other programs available for your specific needs.
The pharmacist & nurse are specialized, experienced and certified in Immune Globulin therapy.
They collaborate in managing your infusion and customize it to your unique needs (product selection, labs, infusion rate, adverse events, clinical response).
Your Infusion Nurse is with you from the beginning to the end of your infusion.
Your Infusion pharmacist, Infusion nurse, and patient advocate are on call 24/7/365, they are always available in the event you need them or have questions.